Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-15T19:15:38.153Z Has data issue: false hasContentIssue false

Synaptophysin gene expression in schizophrenia

Investigation of synaptic pathology in the cerebral cortex

Published online by Cambridge University Press:  02 January 2018

Sharon L. Eastwood
Affiliation:
University Departments of Psychiatry and Clinical Neurology (Neuropathology), Oxford
Nigel J. Cairns
Affiliation:
Department of Neuropathology, Institute of Psychiatry, London
Paul J. Harrison*
Affiliation:
University Departments of Psychiatry and Clinical Neurology (Neuropathology), Oxford
*
Dr P. J. Harrison, Neurosciences Building, University Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX
Rights & Permissions [Opens in a new window]

Abstract

Background

Decreased expression of proteins such as synaptophysin in the hippocampus and prefrontal cortex in schizophrenia is suggestive of synaptic pathology. However, the overall profile of changes is unclear.

Aims

To investigate synaptophysin gene expression in the cerebral cortex in schizophrenia.

Method

The dorsolateral prefrontal (Brodmann area [BA] 9/46), anterior cingulate (BA 24), superior temporal (BA 22) and occipital (BA 17) cortex were studied in two series of brains, totalling 19 cases and 19 controls. Synaptophysin was measured by immunoautoradiography and immunoblotting. Synaptophysin messenger RNA (m RNA) was measured using in situ hybridisation.

Results

Synaptophysin was unchanged in schizophrenia, except for a reduction in BA 17 of one brain series. Synaptophysin mRNA was decreased in BA 17, and in BA 22 in the women with schizophrenia. No alterations were seen in BA 9/46.

Conclusions

Synaptophysin expression is decreased in some cortical areas in schizophrenia. The alterations affect the mRNA more than the protein, and have an unexpected regional distribution. The characteristics of the implied synaptic pathology remain to be determined.

Information

Type
Papers
Copyright
Copyright © 2000 The Royal College of Psychiatrists 
Figure 0

Table 1Demographic details of subjects studied

Figure 1

Fig. 1Autoradiographic images of superior temporal cortex (BA 22) showing synaptophysin mRNA (A, B) and synaptophysin (C, D), detected by in situ hybridisation and immunoautoradiography, respectively. A and C: control subject; B and D: subject with schizophrenia.

Figure 2

Table 2Effects of age, brain pH and post-mortem interval on synaptophysin expression

Figure 3

Table 3Synaptophysin mRNA in the cerebral cortex in schizophrenia

Figure 4

Table 4Synaptophysin mRNA in BA 9/46 pyramidal neurons

Figure 5

Table 5Synaptophysin in the cerebral cortex in schizophrenia

Figure 6

Fig. 2Cartoon illustrating anatomical aspects of synaptophysin expression. The large rectangle represents a cortical area (e.g. BA 9/46). Synaptophysin mRNA is localised to the cell body of neurons (shown in grey), whereas synaptophysin itself is concentrated in their synaptic terminals (black diamonds). The synapses of interneurons (circles) and some of those arising from pyramidal neurons (triangles) are located in the same area. However the main projection of pyramidal neurons is to other brain areas (represented by the smaller rectangle, below, outlined with broken lines), and this fraction of their synaptophysin will not be detected. Equally, some of the synaptophysin (black circle) in the area being studied is in the terminals of neurons whose cell body (open triangle) lies elsewhere, and whose mRNA will therefore not have been measured.

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.